Home / Peptides / Semaglutide

Semaglutide Dosage Chart and Schedule

FDA-approved

Weekly GLP-1 agonist (Ozempic, Wegovy). Wegovy label: 0.25 mg start, up to 2.4 mg, or 7.2 mg (HD).

Also called: Ozempic, Wegovy, Rybelsus, Wegovy HD

Regulatory status (US)

FDA-approved as Ozempic (type 2 diabetes, 2017), Wegovy injection (weight, 2021), Wegovy tablets (25 mg, December 2025), Wegovy HD (7.2 mg weekly, March 2026) and Rybelsus tablets. The semaglutide shortage was declared over in February 2025.

What it is

A GLP-1 receptor agonist peptide with a half-life of about one week, given as a weekly injection or a daily tablet.

Wegovy injection label escalation

WeeksWeekly doseNote
1-40.25 mgStarting dose
5-80.5 mg
9-121 mg
13-161.7 mg
17+2.4 mgMaintenance (or 1.7 mg)
After 4+ weeks on 2.4 mgup to 7.2 mgAdults, weight reduction (Wegovy HD)

From the Wegovy prescribing information. Ozempic (diabetes) uses 0.25 mg for 4 weeks, then 0.5 mg, then 1 mg and a maximum of 2 mg, each step after at least 4 weeks.

Semaglutide reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe. A units chart for every dose step is on the Semaglutide reconstitution calculator page.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Storage

Safety

Compare

Questions

Is Semaglutide FDA-approved?
FDA-approved as Ozempic (type 2 diabetes, 2017), Wegovy injection (weight, 2021), Wegovy tablets (25 mg, December 2025), Wegovy HD (7.2 mg weekly, March 2026) and Rybelsus tablets. The semaglutide shortage was declared over in February 2025.
What dose of Semaglutide has been studied?
1-4: 0.25 mg: Starting dose; 5-8: 0.5 mg; 9-12: 1 mg; 13-16: 1.7 mg; 17+: 2.4 mg: Maintenance (or 1.7 mg); After 4+ weeks on 2.4 mg: up to 7.2 mg: Adults, weight reduction (Wegovy HD). From the Wegovy prescribing information. Ozempic (diabetes) uses 0.25 mg for 4 weeks, then 0.5 mg, then 1 mg and a maximum of 2 mg, each step after at least 4 weeks.
How many units is my Semaglutide dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

Tirzepatide

Weekly GIP and GLP-1 agonist (Mounjaro, Zepbound). Label: 2.5 mg start, +2.5 mg every 4 weeks, max 15 mg.

Orforglipron (Foundayo)

Daily GLP-1 pill from Lilly (Foundayo), approved April 2026. Not a peptide and never reconstituted.

Tesamorelin

GHRH analogue (Egrifta) approved for HIV-associated abdominal fat. Egrifta WR: 1.28 mg daily.

Elamipretide (SS-31)

Mitochondria-targeted peptide (Forzinity), approved 2025 only for Barth syndrome. Label: 40 mg daily.

Sources

  1. Wegovy (semaglutide) US prescribing information, Novo Nordisk
  2. Ozempic (semaglutide) US prescribing information, Novo Nordisk
  3. Rybelsus (semaglutide tablets) US prescribing information
  4. FDA approves higher-dose semaglutide under the national priority voucher program (Mar 2026)
  5. FDA: Dosing errors associated with compounded semaglutide
  6. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
  7. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.